Background: Early diagnosis through newborn screening (NBS) and early treatment of cystic fibrosis (CF) do lead to better prognosis. In the Netherlands, the median age for a clinical diagnosis is six months, and after newborn screening this is 30 days. It is unknown if being diagnosed at the age of six months or before two months leads to a clinically relevant difference of the clinical condition at the time of diagnosis.Aim: The aim of this study is to assess the differences in clinical parameters at diagnosis between children with CF identified by newborn screening (NBS) or by clinical diagnosis (CD) in the Netherlands.Methods: From July 1st, 2007 to January 1st, 2012 all newly diagnosed CF patients were reported to the Dutch Paediatric S...
Newborn screening (NBS) for cystic fibrosis (CF) has been gradually established in several countries...
Newborn screening (NBS) for cystic fibrosis (CF) is increasingly being implemented and is soon likel...
The different clinical manifestations of cystic fibrosis, with variable intensity and timing, often ...
Background: Early diagnosis through newborn screening (NBS) and early treatment of cystic fibrosis (...
NOTE: THE SYMBOLS/SPECIAL CHARACTERS IN THIS ABSTRACT CANNOT BE DISPLAYED CORRECTLY ON THIS PAGE. PL...
OBJECTIVES: To determine whether the improved clinical status after newborn screening (NBS) for cyst...
AbstractBackgroundSeveral studies have demonstrated the benefit of Cystic Fibrosis Newborn Screening...
Background Cystic fibrosis (CF) is a lethal recessive genetic disease caused by loss of function ass...
The diagnosis of cystic fibrosis (CF) has traditionally relied on the presence of clinical features ...
Study objective: comparative evaluation of clinical status of patients with cystic fibrosis (CF) 6–9...
BACKGROUND: A study was undertaken to evaluate whether an early diagnosis by neonatal screening may ...
Background: Newborn screening for cystic fibrosis (NBSCF) was introduced in the Dutch NBS program in...
The introduction and widespread implementation of newborn bloodspot screening (NBS) for cystic fibro...
Background - A study was undertaken to evaluate whether an early diagnosis by neonatal screening may...
Background: Newborn screening (NBS) early-identifies cystic fibrosis (CF), but in CF-screening posit...
Newborn screening (NBS) for cystic fibrosis (CF) has been gradually established in several countries...
Newborn screening (NBS) for cystic fibrosis (CF) is increasingly being implemented and is soon likel...
The different clinical manifestations of cystic fibrosis, with variable intensity and timing, often ...
Background: Early diagnosis through newborn screening (NBS) and early treatment of cystic fibrosis (...
NOTE: THE SYMBOLS/SPECIAL CHARACTERS IN THIS ABSTRACT CANNOT BE DISPLAYED CORRECTLY ON THIS PAGE. PL...
OBJECTIVES: To determine whether the improved clinical status after newborn screening (NBS) for cyst...
AbstractBackgroundSeveral studies have demonstrated the benefit of Cystic Fibrosis Newborn Screening...
Background Cystic fibrosis (CF) is a lethal recessive genetic disease caused by loss of function ass...
The diagnosis of cystic fibrosis (CF) has traditionally relied on the presence of clinical features ...
Study objective: comparative evaluation of clinical status of patients with cystic fibrosis (CF) 6–9...
BACKGROUND: A study was undertaken to evaluate whether an early diagnosis by neonatal screening may ...
Background: Newborn screening for cystic fibrosis (NBSCF) was introduced in the Dutch NBS program in...
The introduction and widespread implementation of newborn bloodspot screening (NBS) for cystic fibro...
Background - A study was undertaken to evaluate whether an early diagnosis by neonatal screening may...
Background: Newborn screening (NBS) early-identifies cystic fibrosis (CF), but in CF-screening posit...
Newborn screening (NBS) for cystic fibrosis (CF) has been gradually established in several countries...
Newborn screening (NBS) for cystic fibrosis (CF) is increasingly being implemented and is soon likel...
The different clinical manifestations of cystic fibrosis, with variable intensity and timing, often ...